Yazar "Oran, Duygu Sultan" seçeneğine göre listele
Listeleniyor 1 - 2 / 2
Sayfa Başına Sonuç
Sıralama seçenekleri
Öğe Optimization of Morris Water Maze protocols : effects of water temperature and hypothermia on spatial learning and memory in aged female rats(Turkish Geriatrics Society, 2024) Oran, Duygu Sultan; Temel, Zeynep; Başer, İbrahim Gökşin; Temizyürek, Arzu; Selcan, AyşinIntroduction: Aging is a highly complex process driven by a multitude of factors. The use of humans in aging research is complicated by many factors (ethical issues; environmental and social factors; long natural life span). Therefore, rats are common models for the study of aging and age-related diseases. The Morris water maze test is one of the most common cognitive tests in studies investigating age-related learning and memory. However, standardized protocols are lacking, which could influence results. This study investigated the effects of water temperature and inter-trial interval on physiological parameters, hippocampus-dependent learning, and memory in aged female rats performing the Morris Water Maze. Materials and Methods: Thirty-two female Wistar Hannover rats, aged over 18 months, were divided into four groups based on water temperature (20 °C or 24 °C) and inter-trial interval (30 seconds or 13 minutes). Results: Rats exposed to 24 °C demonstrated better spatial learning and memory retention than those at 20 °C. The interaction between inter-trial interval and water temperature significantly affected memory, with higher temperatures improving memory, especially with shorter intervals. Inter-trial interval alone did not significantly affect learning, but longer durations were associated with more stable body temperatures. Neither water temperature nor inter-trial interval significantly influenced body weight. Conclusion: These findings emphasize the need to standardize environmental conditions in Morris water maze protocols to enhance research validity and reliability. Optimizing these protocols is crucial to upholding ethical standards and ensuring animal welfare, advancing more effective and scientifically sound practices in gerontological research, and fostering a better understanding of aging processes.Öğe Therapeutic and prophylactic effects of fulvic acid on a breast cancer model established by MCF-7 cell line in SCID mice(2024) Gülçiçek, Osman Bilgin; Oran, Duygu Sultan; Temizyürek, Arzu; Yavuz, Erkan; Yiğitbaş, Hakan; Erçetin, Candaş; Solmaz, Ali; Yıldırım, Funda; Sönmez, Kıvılcım; Çelik, AtillaIntroduction. There is still minimal scientific understanding of effects of fulvic acid (FA) on breast cancer. We investigated the prophylactic, therapeutic, and combined effects of FA in a breast cancer model created using MCF-7 cell line in severe combined immunodeficiency disease (SCID) mice. Results. Four experimental groups were established as the control group (Group C), prophylaxis group (Group P), therapeutic group (Group T), and prophylaxis + therapeutic group (Group P + T). Tumor growth was observed by the in vivo imaging system and macroscopically in mammary glands of all mice (100%) of Group C, microscopically in only one mouse of Group P (12.5%), in four mice in Group T (50%), but only one animal (12.5%) in Group P + T. Immunohistochemistry (IHC) showed that p53 staining was significantly higher in tissues of Group C compared to other groups (P < 0.05). No difference was found in IHC scores for p53 between Group P and P + T (P > 0.05). Bcl-2 staining was significantly higher in Group C compared to Group P + T (P = 0.015) and higher in Group P + T compared to Group T (P = 0.021) but no significant difference was found between Group P and others (P > 0.05). Bax staining was significantly higher in Group C compared to others (P < 0.05) but no significant difference was found between FA groups (P > 0.05). Conclusion. Prophylactic FA treatment can prevent tumor formation by inducing variations in the expression of p53, BcL-2, and Bax proteins in mammary glands of SCID mice before tumor formation. This suggests that FA may be a powerful inhibitory candidate for the prevention of tumorigenesis in breast cancer.